FDA approval

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

“Science Can Change Lives, Spark Revolutions and Perhaps Even Heal the World”

Sensing Fat

Food: Friend, Not Foe – New Study Explains Why

MRI Gets a Nano-Sized Upgrade

Press Releases

“Science Can Change Lives, Spark Revolutions and Perhaps Even Heal the World”

Food: Friend, Not Foe – New Study Explains Why

Wake-Up Call for Dormant Cancer

Most Popular Articles

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Let it Rain

Added particles in the atmosphere could be affecting rainfall patterns

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research